Japan Intellectual Property Rights: METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

Japan, Jan. 20 -- ABBVIE INC has got intellectual property rights for 'METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES.' Other related details are as follows:

Application Number: JP,2024-016902

Category (FI): A61K31/58,A61K39/395@N,A61K45/00,A61P1/00,A61P1/04,A61P11/02,A61P11/06,A61P17/00,A61P27/02,A61P29/00,A61P37/08,A61P43/00,121,C07K16/24

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 7, 2024

Publication Date: April 16, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.